Alligator Bioscience develops antibody-based pharmaceuticals for cancer treatment. The Company is specialized in the development of tumor-targeted immunotherapies, particularly agonistic mono- and bispecific antibodies, and is engaged in the early stages of drug development, from the idea stage to clinical phase II trials.
|Size (employees)||47 (est)+31%|
Alligator Bioscience has 124 Twitter Followers. The number of followers has increased 8.3% month over month and increased 11.5% quarter over quarter